X-linked inhibitor of apoptosis protein is a prognostic marker for a favorable outcome in three identified subsets in resectable adenocarcinoma of the pancreas

PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) is currently one of the leading causes of cancer death worldwide. Therefore, building further subgroups as well as enabling individual patient therapy and diagnostics are needed. X-linked inhibitor of apoptosis protein (XIAP) is known to modulate apop...

Descripción completa

Detalles Bibliográficos
Autores principales: Knipper, Karl, Lyu, Su Ir, Goebel, Heike, Damanakis, Alexander I., Zhao, Yue, Bruns, Christiane J., Schmidt, Thomas, Kashkar, Hamid, Quaas, Alexander, Schiffmann, Lars M., Popp, Felix C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356682/
https://www.ncbi.nlm.nih.gov/pubmed/36472768
http://dx.doi.org/10.1007/s00432-022-04476-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356682/
https://www.ncbi.nlm.nih.gov/pubmed/36472768
http://dx.doi.org/10.1007/s00432-022-04476-2

Ejemplares similares